Related Experiment Video

Updated: May 5, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

7.7K

Strategies for chronic coronary disease: A brief guide for clinicians

Chayakrit Krittanawong1, Muzamil Khawaja2, Hafeez Ul Hassan Virk3

  • 1Cardiology Division, NYU Langone Health and NYU School of Medicine, New York, NY, USA. Chayakrit.Krittanawong@va.gov.

NPJ Cardiovascular Health
|March 3, 2026
PubMed

Insights

The 2023 American Heart Association/American College of Cardiology guidelines emphasize lifestyle changes and medications for chronic coronary disease (CCD) management. These strategies improve cardiovascular outcomes and reduce mortality in patients with CCD.

Area of Science:

  • Cardiology
  • Preventive Medicine

Background:

  • Chronic Coronary Disease (CCD) management requires comprehensive strategies.
  • The American Heart Association (AHA) and American College of Cardiology (ACC) released updated guidelines in 2023.
  • Effective CCD care integrates multiple therapeutic modalities.

Purpose of the Study:

  • To review the 2023 AHA/ACC guidelines for Chronic Coronary Disease (CCD) management.
  • To emphasize the importance of non-pharmacological and pharmacological interventions.
  • To enhance understanding of approaches leading to improved cardiovascular outcomes in CCD patients.

Main Methods:

  • Review of the 2023 Multisociety Guidelines for the Management of Patients with Chronic Coronary Disease (CCD).
  • Analysis of non-pharmacological interventions (lifestyle modifications).
  • Analysis of pharmacological and revascularization treatments.

Main Results:

  • Non-pharmacological interventions like increased physical activity, balanced diet, and smoking cessation are critical.
  • Pharmacological treatments and revascularization optimize cardiac function and reduce adverse events.
  • Combining lifestyle changes with medications improves quality of life and lowers mortality rates.

Conclusions:

  • Adherence to the 2023 AHA/ACC guidelines is crucial for optimal CCD patient care.
  • A multifaceted approach including lifestyle modifications and evidence-based treatments is essential.
  • Integrated management strategies significantly enhance cardiovascular outcomes and patient survival.

More Related Videos

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration07:59

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration

Published on: April 4, 2022

1.5K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.7K

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
891
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
450
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
525
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
495
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
567
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
747